Skip to content

Research at St Andrews

Human urinary exosomes in bladder cancer patients: properties, concentrations and possible clinical application

Research output: Contribution to journalArticle


Open Access permissions



Andrew Clive Riches, Simon John Powis, Peter Mullen, David James Harrison, Christian Hacker, John Milton Lucocq, James Simeon Bowness, Alex Chapman, Ruth Cameron, Liz McLornan, David John Chinn, Steve Leung

School/Research organisations


OBJECTIVE: High grade bladder cancer is extremely aggressive. Early detection is thus an important challenge. De- velopment of non-invasive diagnostic tools particularly using urine samples could be of importance in the diagnosis and surveillance of these patients. Exosomes are small vesicles present in the urine and have the potential to be used as biomarkers of cancer. Thus studies of the properties and concentrations of these particles in bladder cancer patients are of importance.MATERIALS AND METHODS: The concentration of exosomes present in urine was determined by nanoparticle tracking analysis using a Nanosight LM10 unit. Clinical urine samples were routinely collected and fixed using Preservcyt. The morphology of exosomes was studied in electron micrographs and characteristic exosome markers using Western blots.RESULTS: The exosome concentration of fixed samples stored at room temperature was constant for 48 hours and the same as fresh samples. Exosomes derived from patients presenting for a transurethral resection of their bladder tumor exhibited the exosome markers ALIX and TSG101 and also the classic cup shaped appearance in electron micrographs. The concentration of exosomes in patients presenting for transurethral resection of a bladder tumor was significantly greater than in patients presenting for check cystoscopy with no recurrence (median 77.2 × 108 per ml compared with 38.8 × 108 per ml, P < 0.001). A ROC analysis (area under the curve 77.4%) suggested that a suitable cut-off concen- tration of 85 × 108 per ml is associated with a sensitivity of 43% and specificity of 91% for diagnosing bladder cancer.CONCLUSIONS: Thus the concentration and properties of exosomes can be conveniently studied in fixed urine sam- ples derived from bladder cancer patients. The characteristic properties of exosomes were preserved and increased numbers were found in patients presenting for transurethral resection of their tumor. With an appropriate cut-off value, urinary exosome concentrations may have utility in excluding a cancer recurrence when monitoring patients successfully treated for bladder cancer.


Original languageEnglish
Article numbere19
Number of pages7
Issue number3
Publication statusPublished - 11 Dec 2015

    Research areas

  • ALIX, Bladder cancer, Exosomes, TSG101

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Monitoring the Rab27 associated exosome pathway using nanoparticle tracking analysis

    Zheng, Y., Campbell, E. C., Lucocq, J., Riches, A. & Powis, S. J., 15 Jul 2013, In : Experimental Cell Research. 319, 12, p. 1706-13 8 p.

    Research output: Contribution to journalArticle

  2. Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031

    Sarr, A., Bré, J., Um, I. H., Chan, T. H., Mullen, P., Harrison, D. J. & Reynolds, P. A., 21 May 2019, In : Scientific Reports. 9, 13 p., 7643.

    Research output: Contribution to journalArticle

  3. Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer

    Lubbock, A. L. R., Stewart, G. D., O'Mahoney, F. C., Laird, A., Mullen, P., O'Donnell, M., Powles, T., Harrison, D. J. & Overton, I. M., 26 Jun 2017, In : BMC Medicine. 15, 12 p., 118.

    Research output: Contribution to journalArticle

  4. A signaling visualization toolkit to support rational design of combination therapies and biomarker discovery: SiViT

    Brown, J. L., Shovman, M., Robertson, P., Boiko, A., Goltsov, A., Mullen, P. & Harrison, D. J., May 2017, In : Oncotarget. 8, 18, p. 29657-29667 11 p.

    Research output: Contribution to journalArticle

  5. Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells

    Meehan, J., Ward, C., Turnbull, A., Bukowski-Wills, J., Finch, A., Jarman, E. J., Xintaropoulou, C., Martinez-Perez, C., Gray, M., Pearson, M., Mullen, P., Supuran, C. T., Carta, F., Harrison, D. J., Kunkler, I. H. & Langdon, S., 2017, In : Oncotarget. 8, 26, p. 42857-42875

    Research output: Contribution to journalArticle

ID: 240104405